|
This information was adapted from the National Institutes of Health Website
What is a clinical trial?
A clinical trial is a research study that tests a new medical treatment or a new
way of using an existing treatment to see if it will be a better way prevent,
screen for, diagnose or treat a disease. People volunteer to be in a clinical
trial and to answer specific questions about their health. Carefully conducted
clinical trials are the fastest and safest way to find treatments that improve
people’s health.
TOP
What happens during a clinical trial?
A participant in a clinical trial works with a research team that includes doctors
and nurses as well as social workers and other health care professionals. The
team checks the participant’s health at the beginning of the trial, gives
specific instructions for taking part in the trial, observes the participant carefully
during the trial, and stays in touch after the trial is completed. Some clinical
trials involve more tests and doctor visits than is usual for an illness or condition.
Participation in a clinical trial is most successful when the protocol is carefully
followed and there is frequent contact with the research staff.
TOP
What is a protocol?
A protocol is the study plan on which the clinical trial is based. The plan is
carefully designed to protect the health of the participants as well as to answer
specific research questions. A protocol describes what types of people may take
part in the trial; the schedule of tests, procedures, medications, and dosages;
and the how long the study will last. During a clinical trial, participants following
a protocol are seen regularly by the research staff to monitor their health and
to determine the safety and effectiveness of the treatment.
TOP
What are the benefits of being in a clinical trial?
Participants in clinical trials play a more active role in their own health care,
have access to new research treatments before they are widely available, get expert
medical care at leading health care facilities, and help others by contributing
to medical research.
TOP
What are the risks of being in a clinical trial?
There are risks to clinical trials:
- The treatment may have unpleasant, serious or even life-threatening side effects.
- The treatment may not be effective for the participant.
- The protocol may require more of the participant’s time and attention
than a different treatment, including trips to the study site, more treatments,
hospital stays or complex dosage requirements.
TOP
Who pays for clinical trials?
Clinical trials are sponsored or funded by many organizations or individuals such
as physicians, medical institutions, foundations, voluntary groups and pharmaceutical
companies. They are also sponsored by government agencies such as the National
Institutes of Health (NIH), the Department of Defense (DOD) and the Department
of Veteran's Affairs (VA). Trials can take place in many different locations such
as hospitals, universities, doctors' offices and community clinics.
TOP
Who can take part in a clinical trial?
All clinical trials have rules about who can and cannot be in the trial. This
is an important principle of medical research that helps researchers answer the
questions they plan to study. The rules that allow someone to participate in a
clinical trial are called "inclusion criteria" and those that keep someone
out of a trial are called "exclusion criteria." They are based on such
factors as a person’s age, gender, the kind of disease he or she has and
how serious it is, what treatments he or she received before being in the trial,
and whether that person has other medical problems.
It is important to understand that inclusion and exclusion criteria are not
used to reject people personally. They are used to identify the people who are
the most appropriate for that trial and to keep them safe. A participant must
qualify for a clinical trial before joining it. Some research studies need people
who have the disease or condition that will be investigated in the clinical trial,
while other trials need people who are healthy.
TOP
What is informed consent?
Informed consent is learning about and understanding what happens during the clinical
trial before deciding whether or not to be in it. To help someone make that decision,
if they qualify, the doctors and nurses involved in the trial explain the details
of the study. If the participant does not speak English well, he or she can get
help with translation. The research team provides an informed consent document
that includes details about the study such as its purpose, how long it will last,
what procedures are required, and the names of key contacts. The informed consent
document also explains the potential risks and benefits of the trial. Participants
also will get information about how things are going during the trial.
The participant then decides whether or not to sign the document. Informed consent
is not a contract, and you may leave the clinical trial at any time.
TOP
How is the participant’s safety protected?
The ethical and legal codes that govern medical practice also apply to clinical
trials. In addition, most clinical research is regulated by the federal government
with built-in safeguards to protect the participants. The trial follows a carefully
controlled protocol, a study plan which details what researchers will do in the
study. As a clinical trial goes forward, researchers report the results of the
trial at scientific meetings, to medical journals, and to various government agencies.
The names of people taking part in the trial remain secret and are not mentioned
in these reports.
Every clinical trial in the United States must be approved and monitored by
an Institutional Review Board (IRB) to make sure the risks are as low as possible
and are worth any potential benefits. An IRB is an independent committee of physicians,
statisticians, community advocates, and others who make sure that a clinical trial
is ethical and the rights of study participants are protected. All institutions
that conduct or support biomedical research involving people must, by federal
regulation, have an IRB that initially approves and periodically reviews the research.
TOP
Can participants quit a clinical trial after it has
started?
Yes. Participants can leave a clinical trial at any time. If they leave the trial,
they must let the research team know and tell them why they are leaving the study.
TOP
What should people consider before participating in
a trial?
People should know as much as possible about the clinical trial and feel comfortable
asking the members of the health care team questions about the trial, the kind
of care they will receive during the trial and the cost of the trial.
It might be helpful for anyone who is considering taking part in a clinical
trial to discuss the following questions with the research team before making
a decision. Some of the answers to these questions are found in the informed consent
document.
- What is the study for?
- Who is going to be in the study?
- Why do researchers think the new treatment being tested will work? Has it
been tested before?
- What kinds of tests and treatments are involved?
- Are the possible risks, side effects, and benefits in the study different
from my current treatment?
- How might this trial affect my daily life?
- How long will the trial last?
- Will I have to go into the hospital?
- Who will pay for the treatment?
- Will I get money back for other expenses
- What type of long-term follow-up care is part of this study?
- How will I know that the treatment is working? Will I get the results of the
trials?
- Who will be in charge of my care?
TOP
How should participants get ready for the meeting
with the research coordinator or doctor?
- Write down their questions.
- Ask a friend or family member to go with them for support and to hear the
answers to their questions.
- Bring a tape recorder, tape the meeting and listen to it later.
TOP
What are the different types of clinical trials?
- Treatment trials test new treatments, new combinations of drugs, or new approaches
to surgery or radiation therapy.
- Prevention trials look for better ways to prevent disease in people who have
never had the disease or to prevent a disease from returning. These approaches
may include medicines, vitamins, vaccines, minerals, or lifestyle changes.
- Diagnostic trials are conducted to find better tests or procedures for diagnosing
a particular disease or condition.
- Screening trials test the best way to detect certain diseases or health conditions.
- Quality of Life trials (or Supportive Care trials) explore ways to improve
comfort and the quality of life for people with a chronic illness.
TOP
What is a control or control group?
A control is the standard that the research team uses to compare and evaluate
the results of the experiments done in the trial. In many clinical trials, one
group of patients will be given an experimental drug or treatment, while the control
group is given either a standard treatment for the illness or a placebo.
TOP
What is a placebo?
A placebo is a pill, liquid, or powder that looks like medicine but has no medicine
in it and has no effect on people. It is commonly called a “sugar pill.”
In clinical trials, experimental treatments are often compared with placebos to
assess the treatment's effectiveness. In some studies, the participants in the
control group receive a placebo instead of an active drug or treatment.
TOP
What are side effects and adverse reactions?
Side effects are any undesired actions or effects of a drug or treatment. Negative
or adverse effects may include headache, nausea, hair loss, skin irritation, or
other physical problems. Experimental treatments must be evaluated for both immediate
and long-term side effects.
TOP
What are the phases of clinical trials?
Clinical trials are conducted in phases. Each phase of a trial has a different
purpose and helps scientists answer different questions:
- In Phase I trials, researchers test a new drug or treatment in a small group
of people (20-80) for the first time to evaluate its safety, determine a safe
dosage range, and identify side effects.
- In Phase II trials, the study drug or treatment is given to a larger group
of people (100-300) to see if it is effective and to further evaluate its safety.
- In Phase III trials, the study drug or treatment is given to large groups
of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare
it to commonly used treatments, and collect information that will allow the drug
or treatment to be used safely.
- Phase IV trials studies are done after a drug has been approved that gather
additional information including the drug's risks, benefits, and optimal use.
TOP
Do participants still see their primary doctor while
they are in a trial?
Yes. Most clinical trials provide short-term treatments related to a designated
illness or condition, but do not provide extended or complete primary health care.
In addition, by having the health care provider work with the research team, the
participant can ensure that other medications or treatments will not conflict
with the protocol.
TOP |
|
|